Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription Articles published in Eur J Obstet Gynecol Reprod Biol Retrieve available abstracts of 76 articles: HTML format

Single Articles

September 2024
1. AKSAN A, Boran N, Sinem Duru Coteli A, Ustun Y, et al
   Ultra-radical surgery versus standard-radical surgery for the primary cytoreduction of advanced epithelial ovarian cancer; long-term tertiary center experiences.
   Eur J Obstet Gynecol Reprod Biol. 2024;302:125-133.
   PubMed     Abstract available
   
   
   July 2024
2. SCALIA P, Levin G, Lau S
   Pembrolizumab for metastatic squamous cell carcinoma arising from mature teratoma of the ovary: A letter to the editor.
   Eur J Obstet Gynecol Reprod Biol. 2024 Jul 31:S0301-2115(24)00421.
   PubMed    
   
   
   June 2024
3. ABU-ZAID A, Baradwan S, Alyafi M, Al Baalharith M, et al
   Association between polycystic ovary syndrome and the risk of malignant gynecologic cancers (ovarian, endometrial, and cervical): A population-based study from the U.S.A. National Inpatient Sample 2016-2019.
   Eur J Obstet Gynecol Reprod Biol. 2024;299:283-288.
   PubMed     Abstract available
   
   
   
4. MOSS E, Taylor A, Andreou A, Ang C, et al
   British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024.
   Eur J Obstet Gynecol Reprod Biol. 2024;300:69-123.
   PubMed    
   
   
   
5. PERGIALIOTIS V, Feroussis L, Papadatou K, Vlachos DE, et al
   Diaphragmatic stripping in epithelial ovarian cancer at first diagnosis: Impact on morbidity and survival outcomes.
   Eur J Obstet Gynecol Reprod Biol. 2024;299:225-230.
   PubMed     Abstract available
   
   
   May 2024
6. LEBEAU J, Leung J, Bernard L, Zeng X, et al
   Phlegmasia cerulea dolens - A rare presentation of ovarian malignancy.
   Eur J Obstet Gynecol Reprod Biol. 2024 May 25:S0301-2115(24)00259.
   PubMed    
   
   
   
7. MIAO K, Lv Q, Zhang L, Zhao N, et al
   Discriminative diagnosis of ovarian endometriosis cysts and benign mucinous cystadenomas based on the ConvNeXt algorithm.
   Eur J Obstet Gynecol Reprod Biol. 2024;298:135-139.
   PubMed     Abstract available
   
   
   April 2024
8. HU D, Qian J, Yin F, Wei B, et al
   Evaluation of serum CA125, HE4 and CA724 and the risk of ovarian malignancy algorithm score in the diagnosis of high-grade serous ovarian cancer.
   Eur J Obstet Gynecol Reprod Biol. 2024;297:170-175.
   PubMed     Abstract available
   
   
   
9. GAO Y, Zang L, Ye Y, Ma F, et al
   Immunotherapy combined with targeted therapy in advanced small cell carcinoma of the ovary of hypercalcemic type: A case of overall survival lasting for over 5 years.
   Eur J Obstet Gynecol Reprod Biol. 2024 Apr 6:S0301-2115(24)00168.
   PubMed     Abstract available
   
   
   March 2024
10. NATARAJAN P, Martha Schofield A, Elena Vinturache A, Ruthven S, et al
    A comparison of the clinical and histological appearances after treatment of advanced stage ovarian cancer with PlasmaJet(R) device.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:311-315.
    PubMed     Abstract available
    
    
    
11. GUZEL D, Terek C, Besler A, Serin G, et al
    PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
    Eur J Obstet Gynecol Reprod Biol. 2024;296:321-326.
    PubMed     Abstract available
    
    
    
12. RODOLAKIS I, Liontos M, Pergialiotis V, Haidopoulos D, et al
    Chemotherapy response score as a predictor of survival in ovarian cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:233-238.
    PubMed     Abstract available
    
    
    
13. DABI Y, Rockall A, Razakamanantsoa L, Guerra A, et al
    O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:135-142.
    PubMed     Abstract available
    
    
    
14. MALIK N, Sahu B
    Counselling and management of women with genetic predisposition to gynaecological cancers.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:44-48.
    PubMed     Abstract available
    
    
    February 2024
15. BRAUN C, Grunig H, Peikert J, Strobel K, et al
    Do PET-positive supradiaphragmatic lymph nodes predict overall survival or the success of primary surgery in patients with advanced ovarian cancer?
    Eur J Obstet Gynecol Reprod Biol. 2024;296:13-19.
    PubMed     Abstract available
    
    
    
16. GUO L, Kang X, Su Y, Liu X, et al
    Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:107-113.
    PubMed     Abstract available
    
    
    
17. SHIBAHARA M, Kurita T, Harada H, Tsuda Y, et al
    Therapeutic management of uterine tumours resembling ovarian sex cord tumours including a focus on fertility: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2024;295:1-7.
    PubMed     Abstract available
    
    
    January 2024
18. KATSANEVAKIS E, Addo-Yobo W, Bharathan B, Loona A, et al
    Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:105-110.
    PubMed     Abstract available
    
    
    
19. NIE X, Xu T, Zhang L, Cheng W, et al
    The Gustave Roussy immune score as a novel scoring system for predicting platinum resistance in advanced high-grade serous ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:97-104.
    PubMed     Abstract available
    
    
    
20. PETIOT F, Descargues P, Devouassoux-Shisheboran M, You B, et al
    Retrospective analysis of uterine involvement in low grade serous ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:191-197.
    PubMed     Abstract available
    
    
    November 2023
21. LIBERIS A, Kyziridis D, Kalakonas A, Tentes AA, et al
    Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer: 18 years of experience.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:102-106.
    PubMed     Abstract available
    
    
    
22. LUIS ALCAZAR J, Ramon Perez-Vidal J, Tameish S, Chacon E, et al
    Ultrasound for assessing tumor spread in ovarian cancer. A systematic review of the literature and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:194-200.
    PubMed     Abstract available
    
    
    
23. SHARON A, Aiob A, Kais M, Apel-Sarid L, et al
    Detection and dissection of sentinel nodes in endometrial endometrioid cancer with indocyanine green using PinPoint laparoscopy: Analysis of the learning curve.
    Eur J Obstet Gynecol Reprod Biol. 2023;292:91-96.
    PubMed     Abstract available
    
    
    September 2023
24. LEMS E, Leemans JC, Lok CAR, Bongers MY, et al
    Current uptake and barriers to wider use of the International Ovarian Tumor Analysis (IOTA) models in Dutch gynaecological practice.
    Eur J Obstet Gynecol Reprod Biol. 2023;291:240-246.
    PubMed     Abstract available
    
    
    July 2023
25. PENG Y, Ur Rehman Aziz A, Wang Y, Li Q, et al
    Ovarian steroid cell tumour, not otherwise specified: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2023 Jul 28:S0301-2115(23)00300.
    PubMed    
    
    
    April 2023
26. TZANIS AA, Antoniou SA, Zacharoulis D, Ntafopoulos K, et al
    The role of systematic pelvic and para-aortic lymphadenectomy in the management of patients with advanced epithelial ovarian, tubal, and peritoneal cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2023;285:198-203.
    PubMed     Abstract available
    
    
    March 2023
27. MATSUO K, Rau AR, Machida H, Roman LD, et al
    Intraoperative rupture and chemotherapy use in stage I ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2023 Mar 20:S0301-2115(23)00105.
    PubMed    
    
    
    January 2023
28. RALSER DJ, Condic M, Otten LA, Koensgen D, et al
    Evolving treatment landscape of advanced endometrial cancer - A current perspective from a German tertiary referral center for gynecological oncology.
    Eur J Obstet Gynecol Reprod Biol. 2023;282:61-63.
    PubMed    
    
    
    November 2022
29. VALENTI G, Sopracordevole F, Chiofalo B, Forte S, et al
    Parenchymal liver metastasis in advanced ovarian cancer: Can bowel involvement influence the frequency and the related mortality rate?
    Eur J Obstet Gynecol Reprod Biol. 2022;280:48-53.
    PubMed     Abstract available
    
    
    
30. YIN J, Li Y, Wang H, Wang W, et al
    Clinical outcomes of levonorgestrel-releasing intrauterine device present during controlled ovarian stimulation in patients with early stage endometrioid adenocarcinoma and atypical endometrial hyperplasia after fertility-sparing treatments: 10-year e
    Eur J Obstet Gynecol Reprod Biol. 2022;280:83-88.
    PubMed     Abstract available
    
    
    
31. VAN TRAPPEN P, de Cuypere E, Claes N
    Robotic surgery in early and advanced ovarian cancer: Case selection for surgical staging and interval debulking surgery.
    Eur J Obstet Gynecol Reprod Biol. 2022;280:7-11.
    PubMed     Abstract available
    
    
    October 2022
32. HUBER D, Fournier I, Christodoulou M, Seidler S, et al
    Stapled diaphragm resection: A new approach to diaphragmatic cytoreductive surgery for advanced-stage ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2022;279:88-93.
    PubMed     Abstract available
    
    
    September 2022
33. MATAN LS, Perri T, Kogan L, Brandt B, et al
    Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.
    Eur J Obstet Gynecol Reprod Biol. 2022;278:166-171.
    PubMed     Abstract available
    
    
    
34. RODRIGUES TEIXEIRA F, Vertematti de Castro V, Chaves Faloppa C, Mantoan H, et al
    Impact of lymph node staging in presumed early-stage ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2022;278:6-10.
    PubMed     Abstract available
    
    
    June 2022
35. ROSATI A, Fedele C, Fagotti A, Lafuenti L, et al
    Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impact.
    Eur J Obstet Gynecol Reprod Biol. 2022;273:1-6.
    PubMed     Abstract available
    
    
    March 2022
36. ASSAF W, Andraous M, Lavie O, Segev Y, et al
    Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
    Eur J Obstet Gynecol Reprod Biol. 2022;272:48-54.
    PubMed     Abstract available
    
    
    February 2022
37. GRAHAM R, MacDonald ND, Lockley M, Miller R, et al
    Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2022;271:138-144.
    PubMed     Abstract available
    
    
    December 2021
38. SOBICZEWSKI P, Piatek S, Michalski W, Kupryjanczyk J, et al
    Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
    Eur J Obstet Gynecol Reprod Biol. 2021;269:126-131.
    PubMed     Abstract available
    
    
    
39. VALENTI G, Vitagliano A, Morotti M, Giorda G, et al
    Risks factors for anastomotic leakage in advanced ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;269:3-15.
    PubMed     Abstract available
    
    
    November 2021
40. WANG M, Liu K
    Advances in fertility preserving surgery for borderline ovarian tumors.
    Eur J Obstet Gynecol Reprod Biol. 2021;270:206-211.
    PubMed     Abstract available
    
    
    
41. SHIGEYAMA M, Yoshihara M, Kitami K, Mogi K, et al
    Long-term post-recurrence survival outcomes in young women receiving fertility-sparing surgery for epithelial ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:221-225.
    PubMed     Abstract available
    
    
    
42. LIANG X, Zeng H, Chen S, Jiang M, et al
    Ovarian metastasis risk factors in endometrial carcinoma: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:245-255.
    PubMed     Abstract available
    
    
    
43. CHEN Y, Han L, Zheng A
    Association between statin use and the risk, prognosis of gynecologic cancer: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;268:74-81.
    PubMed     Abstract available
    
    
    October 2021
44. OU YC, Fu HC, Lan J, Wu CH, et al
    The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:99-104.
    PubMed     Abstract available
    
    
    
45. FRIEDRICH L, Meyer R, Levin G
    Management of adnexal mass: A comparison of five national guidelines.
    Eur J Obstet Gynecol Reprod Biol. 2021;265:80-89.
    PubMed     Abstract available
    
    
    
46. KERSHAW V, Hickey I, Wyld L, Jha S, et al
    The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;265:7-17.
    PubMed     Abstract available
    
    
    
47. JEFFERY HE, Gillespie AM, Macdonald M
    Evaluation of women referred to the two-week wait gynaecology clinic with suspected ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2021;266:145-149.
    PubMed     Abstract available
    
    
    August 2021
48. LIU G, Wang Y, Chen Y, Ren F, et al
    Malignant transformation of abdominal wall endometriosis: A systematic review of the epidemiology, diagnosis, treatment, and outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:363-367.
    PubMed     Abstract available
    
    
    July 2021
49. SHARMA JB, Kumar R, Singh U, Kumari A, et al
    Pre treatment and post treatment positron emission tomography-computed tomography (PET-CT) to evaluate treatment response in tuberculous Tubo-Ovarian masses.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:128-134.
    PubMed     Abstract available
    
    
    
50. KANNEGANTI A, Bhadiraju P, Tong PSY
    Extragonadal teratomas in women and adolescent girls: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:134-141.
    PubMed     Abstract available
    
    
    June 2021
51. NEF J, Huber DE
    Ovarian Sertoli-Leydig cell tumours: A systematic review of relapsed cases.
    Eur J Obstet Gynecol Reprod Biol. 2021;263:261-274.
    PubMed     Abstract available
    
    
    April 2021
52. CHOU HH, Chen WC, Yang LY, Huang HJ, et al
    Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trial.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:13-20.
    PubMed     Abstract available
    
    
    
53. ATHEY RA, Macdonald MC, Jha S
    Stage of ovarian cancer at diagnosis. Does presentation as an emergency make a difference?
    Eur J Obstet Gynecol Reprod Biol. 2021;261:7-11.
    PubMed     Abstract available
    
    
    March 2021
54. ALMAHDY AM, Elassall GM, Abdelbadee AY, Abd-Elkariem AY, et al
    Prognostic value of systematic lymphadenectomy in patients with ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:179-185.
    PubMed     Abstract available
    
    
    
55. GKROZOU F, Pappa C, Tsonis O, Dimitriou E, et al
    Relaxin as a potential diagnostic biomarker for ovarian cancer- A prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:99-104.
    PubMed     Abstract available
    
    
    February 2021
56. CAPMAS P, Suarthana E, Tulandi T
    Further evidence that endometriosis is related to tubal and ovarian cancers: A study of 271,444 inpatient women.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:105-109.
    PubMed     Abstract available
    
    
    November 2020
57. ZHANG JL, Li DF, Li DY, Ma LG, et al
    A rare malignant transformation of endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2020 Nov 27. pii: S0301-2115(20)30741.
    PubMed    
    
    
    
58. BOURDEL N, Huchon C, Abdel Wahab C, Azais H, et al
    Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Eur J Obstet Gynecol Reprod Biol. 2020 Nov 20. pii: S0301-2115(20)30758.
    PubMed     Abstract available
    
    
    
59. CARBONE MV, Cavaliere AF, Fedele C, Vidiri A, et al
    Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:326-332.
    PubMed     Abstract available
    
    
    
60. ZILLIOX M, Lecointre L, Azais H, Ballester M, et al
    Management of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:412-418.
    PubMed     Abstract available
    
    
    
61. VOUTSADAKIS IA
    A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:172-178.
    PubMed     Abstract available
    
    
    
62. TANG X, Zhang X, Liu X, Zheng T, et al
    A novel laparoscopy-based model for the prediction of optimal cytoreduction and prognosis of epithelial ovarian cancer in a Chinese population.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:256-262.
    PubMed     Abstract available
    
    
    
63. FONNES T, Telle IO, Forsse D, Falck R, et al
    Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:25-31.
    PubMed     Abstract available
    
    
    October 2020
64. KONSGEN D, Klinkmann G, Kaul A, Diesing K, et al
    Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:154-159.
    PubMed     Abstract available
    
    
    
65. KOLEHMAINEN AM, Pasanen AM, Koivisto-Korander RL, Butzow RC, et al
    Molecular characterization in the prediction of disease extent in endometrial carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2020 Oct 16. pii: S0301-2115(20)30669.
    PubMed     Abstract available
    
    
    
66. ZHAO J, Wu J, Zuo W, Kang S, et al
    A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene is associated with platinum-based chemotherapeutic response and prognosis in epithelial ovarian cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:183-189.
    PubMed     Abstract available
    
    
    
67. FERRARI F, Ficarelli S, Forte S, Valenti G, et al
    Extra-abdominal ovarian cancer presenting with breast metastases at diagnosis: Case report and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:211-221.
    PubMed     Abstract available
    
    
    September 2020
68. YOSHIHARA M, Tamauchi S, Iyoshi S, Kitami K, et al
    Does uterine preservation affect survival outcomes of patients with stage I ovarian sex cord-stromal cell tumours? A multi-institutional study.
    Eur J Obstet Gynecol Reprod Biol. 2020;254:52-56.
    PubMed     Abstract available
    
    
    August 2020
69. CHEN S, Yang B, Fan J
    Diagnostic value of Anti-Mullerian hormone in ovarian granulosa cell tumor: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;253:266-272.
    PubMed     Abstract available
    
    
    July 2020
70. KHIAT S, Provansal M, Bottin P, Saias-Magnan J, et al
    Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2020;253:65-70.
    PubMed     Abstract available
    
    
    March 2020
71. CHEVROT A, Hequet D, Fauconnier A, Huchon C, et al
    Impact of surgical restaging on recurrence in patients with borderline ovarian tumors: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:227-232.
    PubMed     Abstract available
    
    
    January 2020
72. RUDAITIS V, Mikliusas V, Januska G, Jukna P, et al
    The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2020;247:26-31.
    PubMed     Abstract available
    
    
    
73. NASIOUDIS D, Mastroyannis SA, Haggerty AF, Giuntoli RL 2nd, et al
    Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:63-70.
    PubMed     Abstract available
    
    
    November 2019
74. OTIFY M, Laios A, Elshamy T, D'Angelo A, et al
    A systematic review and meta-analysis of the use of ultrasound to diagnose borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:120-127.
    PubMed     Abstract available
    
    
    
75. TARANNUM A, Sheikh H, Appiah-Sakyi K, Lindow SW, et al
    The diagnostic use of magnetic resonance imaging for acute abdominal and pelvic pain in pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2019 Nov 22. pii: S0301-2115(19)30542.
    PubMed     Abstract available
    
    
    
76. RETTENMAIER MA, Micha JP, Bohart R, Goldstein BH, et al
    A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:101-105.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.